Taylor Wessing

		New ECJ reference on Article 87(2) – advertising of medicinal products

		House of Lords triggers a flurry of activity on genomic medicine

		New US Risk Evaluation and Mitigation Strategies

		ECJ ruling on SPCs may present new opportunities for managing product exclusivity life cycles

		Supply and distribution agreements - consultation on EU Rules

		£73m to buy-back your own IP? *Butters and others v BBC Worldwide*

		German parliament adopts amended patent law bill

		Is it the end of the road for compulsory licences under TRIPs?

		A walk in the park? Practical implications of managing the role of NEDs if the Walker Review is adopted

		Companies Act 2006 - now fully implemented

		Promoting Your Business - A legal checklist

		Enviromental highlights for LSH companies

The Life Sciences and Healthcare Group regularly comment, present seminars and publish articles on other legal developments that may be relevant to your business. Click here to view our Topical Issues page and here to view our Events page.

To view our InFocus archive, please click here.

If you have any comments on the contents or the new format please use the feedback form below.

To opt-out from future communications please visit: http://e-updates.taylorwessing.com/vtu/Q90JV7091ZjH59L91

© Taylor Wessing LLP 2009
This publication is intended for general guidance only and no responsibility is accepted by Taylor Wessing LLP for any errors or omissions. The information in this publication should not be relied upon to replace professional advice on specific matters. Taylor Wessing LLP is a limited liability partnership registered in England and Wales, registered number 0C322935, with its registered office at 5 New Street Square, London EC4A 3TW.
Taylor Wessing LLP operates in combination with associated legal entities in other locations.